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Determining Terbinafine in Plasma and Saline Using HPLC
SHERRY COX,1 JOAN HAYES,1 MALLERY HAMILL,1 ALI MARTIN,1 NEALY PISTOLE,1 JASON YARBROUGH,2 and
MARCY SOUZA1
1Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville,
Tennessee, USA
2Siemens Molecular Imaging, Knoxville, Tennessee, USA
A simple, sensitive, and accurate high-performance liquid chromatography (HPLC) method for the determination of terbinafine
concentrations in small-volume plasma and saline has been developed. Following a liquid extraction using hexane, samples were
separated by reversed-phase HPLC on a Symmetry Shield RP18 (5 mm) 4.6 mm 100 mm column and quantified using ultraviolet
detection at 224 nm. The mobile phase was a mixture of water, phosphoric acid, and triethylamine (pH 3.0), with acetonitrile
(65:35, v=v), at a flow rate of 1.1 mL=min. The standard curve ranged from 5 to 1500 ng=mL for parrot plasma and 1 to 25 mg=mL
for 0.9% saline. Intra- and inter-assay variability for terbinafine was less than 10% for both matrices, and the average recovery
was greater than 90%. This method has been developed in parrot plasma and should be applicable to other species, making it useful
to those investigators dealing with small sample volumes, particularly when conducting pharmacokinetic studies that require
multiple sampling from the same animal. This method would also be valuable to aquariums that need to determine terbinafine
concentrations in salt water.
Keywords: extraction, HPLC, plasma, saline, terbinafine, UV detection
Introduction
Terbinafine, (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-
1-naphthalenemethanamine, is an allylamine with a broad
range of in vitro antifungal activity.[1] Terbinafine inhibits
squalene epoxidase, which is an enzyme involved in the
synthesis of ergosterol, which gives terbinafine both fungi-
cidal and fungistatic activity.[1] Historically, terbinafine has
been used in humans to treat dermatophytosis. It has recently
been found to be useful for the treatment of refractory and
systemic fungal infections, particularly those caused by
Aspergillosis sp.,[1] and may also be useful in the treatment
of other systemic fungal diseases of animals.
Terbinafine concentrations have been determined using
high-performance liquid chromatography (HPLC) methods
with UV detection[1–15] and mass spectrometry (MS)[16] in
plasma, tissue, urine, pharmaceutical products, and hair.
MS can produce results with a lower limit of detection
(LOD), but it may not be readily available in all laboratories
due to the cost. Many extraction methods have been tried
including solid-phase extraction (SPE),[2,3,11,16] multistep
extractions, and hydrolysis reactions.[1,4,6–10,14,15] The exist-
ing SPE methods all require much larger sample sizes, and
one method[11] is validated for urine and not plasma. The
Baranowska et al.[3] method requires sample pretreatment
with methanol, acetonitrile, and phosphate buffer prior to
extraction, while the Gurule et al. method[16] requires sample
pretreatment with phosphoric acid and has a recovery range
of 78–87%. The aim of this article is to describe a simple,
sensitive, and accurate method for extracting terbinafine
from plasma and saline samples that eliminates the need
for solid-phase cartridges and time-consuming hydrolysis
reactions. To our knowledge, no method for the analysis
of terbinafine has been reported for saline samples which
could be valuable to aquariums that need to determine terbi-




The chromatography system consisted of a Model 2695
separation module and a Model 2487 ultraviolet detector
(Waters, Milford, MA, USA). Separation was achieved on
a Waters Symmetry Shield RP18 (4.6 mm 100 mm, 5 mm)
column preceded by a 5 mm Symmetry Shield RP18
(3.9 mm 20 mm) guard column. The mobile phase was an
isocratic mixture of A (1.5 mL 85% phosphoric acid, 1 mL
trimethylamine in water, adjusted to pH 3.0 with 1 N sodium
hydroxide) and B (acetonitrile (65:35)). All solutions were
filtered through a 0.22 mm filter and degassed before use.
The water was replaced on a daily basis. The flow rate was
1.1 mL=min, and the ultraviolet detector was set at a wave-
length of 224 nm. The column and autosampler temperature
were ambient which was 23C.
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Reagents
Terbinafine HCl (Figure 1) was purchased from US
Pharmacopeia (Rockville, MD, USA) and was 99% pure.
Butenafine HCl (Figure 1), which was used as the internal
standard (99% purity), was purchased from Toronto Research
Chemicals (Toronto, Ontario, Canada). Triethylamine was
purchased from Sigma-Aldrich (St. Louis, MO, USA). All
other reagent grade chemicals and solvents were purchased
from Fisher Scientific (Pittsburg, PA, USA). Water (18.2 mega-
ohm) was obtained from a Barnstead Nanopure Infinity
(Dubuque, IA, USA) ultrapure water system.
Preparation of Calibration Standards
Five milligrams each of terbinafine and butenafine (internal
standard) were weighed and dissolved in methanol to
produce stock concentrations of 100 mg=mL. Dilutions of
the terbinafine stock solution were prepared in methanol
to produce 0.1, 1, and 10 mg=mL working stock solutions,
while dilutions of the butenafine stock solution were made
to produce a 1 mg=mL working stock solution. Standards
were aliquoted into 2 mL vials to prevent evaporation and
cross-contamination. All solutions were protected from light
in bottles wrapped in aluminum foil and stored at 4C. By
comparing standard areas over time, it was determined that
solutions were stable for a minimum of 6 months.
For preparation of calibration standards and quality
control samples, appropriate volumes of stock solutions
were placed in screw top tubes and evaporated with nitrogen
gas and then untreated parrot plasma, or 0.9% saline was
added. The final concentrations for the plasma calibration
standard curve were 5, 10, 25, 50, 100, 250, 500, 800, 1000,
and 1500 ng=mL with quality control standards of 15, 350,
and 1200 ng=mL. The final concentrations for the saline
standard curve were 1, 2.5, 5, 7.5, 10, 15, and 25 mg=mL with
quality control standards of 3, 12, and 20 mg=mL. Cali-
bration standards and control samples were treated the same
as test samples. The calibration curve was constructed by
using the ratio of the peak area of the analyte divided by
the peak area of the internal standard versus the concen-
tration. Linearity was assessed by unweighted linear
regression analysis. The calibration curve had a correlation
coefficient of 0.99 or better. The acceptance criterion for
each back-calculated standard and quality control concen-
tration was 15% deviation from the nominal value except
lower limit of quantification (LLOQ), which was set at 20%.
Sample Extraction
Terbinafine was extracted from parrot plasma and saline
using a liquid extraction. Previously frozen plasma or saline
samples were thawed, and 100 mL was placed into a 7 mL
screw cap tube. Seventy-five microliters of butenafine (inter-
nal standard, 1 mg=mL) for plasma or 10 mL of butenafine
(internal standard, 100 mg=mL) for saline was added. The
tubes were vortex mixed at a high speed for 5 s to mix solu-
tions, and then 3 mL of hexane was added. Tubes were then
capped and rocked for 20 min before centrifugation at 1000g
for 15 min. The supernatant was removed and placed in a
clean 16 100 glass test tube and then evaporated with
nitrogen. After evaporation, they were redissolved in
250 mL of the mobile phase, vortex mixed for 5 s at high
speed, and centrifuged for another 5 min at 1000g. The
supernatant was placed in total recovery chromatographic
vials (Waters) and 100 mL injected into the system.
Results
Plasma
For specificity testing, untreated plasma was prepared in the
same manner as study samples, and no endogenous plasma
components interfered with the elution of the compounds
of interest. Five different blank plasma samples from adult
male and female parrots were used in the pre-validation pro-
cess, and a blank sample from each animal was included in
the analysis. Figure 2 illustrates chromatograms of a (A)
blank plasma sample, (B) a 800 ng=mL spiked plasma stan-
dard, and (C) a plasma sample from a parrot after oral
administration of a 60 mg=kg dose of terbinafine. The reten-
tion times in plasma were 6.30 and 8.88 min for terbinafine
and butenafine. The method for plasma analysis produced
a linear curve for the concentration range used (5–1500 ng=
mL) with a correlation coefficient of 0.997. The mean slope,
intercept, and r2 values are reported in Table 1. Intra- and
inter-day assay relative standard deviation (RSD) for plasma
spiked with specific concentrations of terbinafine was used to
determine the accuracy and precision which ranged from
2.2% to 9.1% (Tables 1 and 2). The recovery of terbinafine
from spiked plasma was compared to directly injected ana-
lytes at concentrations of 15, 350, and 1200 ng=mL dissolved
in mobile phase without undergoing extraction. The average
recovery ranged from 85% to 90% for terbinafine (Table 2).
The recovery of the internal standard was 81%. The LOD
Fig. 1. Structures of terbinafine and butenafine.
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was 2.5 ng=mL, which represents a peak approximately three
times the baseline noise, and the LLOQ was 5 ng=mL, which
represents a peak approximately five times the baseline
noise. Testing of the short-term stability of the quality
control standards indicated there was less than an 18% loss
of drug after 24 hr in the auto sampler and a 12% loss after
24 hr in the refrigerator at 4C.
Figure 3 is a representative concentration–time profile from
a terbinafine pharmacokinetic study conducted in Amazon
parrots after receiving a 60 mg=kg oral dose of terbinafine.
Fig. 2. Chromatograms for terbinafine. (A) Blank parrot plasma, (B) 800 ng=mL spiked plasma standard, (C) a parrot plasma
sample 30 min after a 60 mg=kg oral dose of terbinafine was administered, (D) blank saline, (E) 5mg=mL spiked saline standard,
and (F) a saline sample from a 37C incubator.
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Saline
Blank saline was subjected to the extraction procedure to
ensure the absence of any peaks at the retention times of
the peaks of interest. Four different saline samples were used
in the pre-validation process, and a blank sample from each
batch was included in the analysis. Figure 2 illustrates
chromatograms of a (D) blank saline, (E) 5 mg=mL spiked
saline sample, and (F) saline from an implant sample placed
in a 37C incubator. The retention times of terbinafine and
butenafine were 6.30 and 8.88 min. This method produced
a linear curve for the concentration range used (1–25 mg=
mL) with a correlation coefficient of 0.992. The mean slope,
intercept, and r2 values are reported in Table 3. Intra- and
inter-day assay RSD for saline spiked with specific
concentrations of terbinafine was used to determine the
accuracy and precision, which ranged from 2.4% to 8.2%
(Tables 3 and 4). The recovery of terbinafine from spiked
saline was determined by comparing the areas of extracted
saline samples to those of directly injected analytes at con-
centrations 3, 12, and 20 mg=mL without undergoing extrac-
tion. The average recovery ranged from 97% to 105% for
terbinafine (Table 4). The recovery of the internal standard
was 108%. The LOD was 0.0025 mg=mL, which represents
a peak approximately three times the baseline noise, and
the LLOQ was 0.005 mg=mL, which represents a peak
approximately five times the baseline noise. Testing of the
short-term stability of the standards at concentrations indi-
cated there was less than an 18% loss of drug after 24 hr in
the auto sampler, and a 6% loss after 24 hr in the refrigerator
at 4C.
Table 3. Intra-assay accuracy, precision, and assay linearity for
terbinafine in saline




(mg=mL) (mean SD) RSD (%)
3 3 0.19 5.9
12 12 0.79 6.8
20 21 0.83 4.0
Assay linearity (n¼ 5)
MeanSD RSD (%)
Y-intercept 0.0393 0.1061 2.3
Slope 0.121 0.014 11.5
r2 0.992 0.008 0.8
SD: standard deviation; n: number of samples; RSD: relative standard
deviation.
Fig. 3. Concentration time profile of terbinafine in a parrot after a 60 mg=kg oral dose.
Table 1. Intra-assay accuracy, precision, and assay linearity for
terbinafine in plasma




(ng=mL) (meanSD) RSD (%)
15 14 1 9.2
350 349 8 2.2
1200 1226 83 6.8
Assay linearity (n¼ 5)
MeanSD RSD (%)
Y-intercept 0.0168 0.0160 5.6
Slope 0.00191 0.00009 4.7
r2 0.9972 0.0005 0.05
SD: standard deviation; n: number of samples; RSD: relative standard
deviation.
Table 2. Inter-assay variability and recovery for terbinafine in









15 15 1 8.6 98
350 357 14 4.0 87
1200 1243 34 2.7 85
SD: standard deviation; n: number of days; RSD: relative standard
deviation.










3 3 0.27 8.2 97
12 12 0.34 2.9 101
20 20 0.49 2.4 105
SD: standard deviation; n: number of days; RSD: relative standard
deviation.
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The goal of the implant study was to investigate a
terbinafine impregnated implant designed for subcutaneous
placement over the dorsum of bats infected with Geomyces
pseudogymanoascus. The first phase of the study was to place
the implant in saline at two different temperatures, 4C and
37C, and determine the concentrations released over the
course of approximately 6 months. Figure 4 is a representa-
tive profile of terbinafine from this study.[17]
Discussion
We wanted to develop a simple method that did not require
SPE cartridges or lengthy hydrolysis reactions. During
method development, several organic solutions and mixtures
were investigated for analyte recovery including methylene
chloride, ethyl acetate, acetonitrile, ethyl acetate and hexane,
methanol, and chloroform. Ethyl acetate and hexane,
methylene chloride, chloroform, and ethyl acetate were
found to produce 68%, 55%, 30%, and 60% recoveries, while
extractions with acetonitrile and methanol decreased the
peak resolution and produced interfering peaks. Once
hexane was selected as the extraction solvent, we wanted
to determine the appropriate volume for the extraction
process and found that 2 mL produced a recovery of roughly
80% and 4 mL produced the same recovery as the 3 mL
which was selected. We also checked varying methods for
mixing the samples and determined that rocking the samples
produced a greater recovery than vortexing for 60 s.
This HPLC method quantifies terbinafine from plasma
and saline by combining a liquid–liquid extraction procedure
with ultraviolet detection. To our knowledge, this is the first
reported method for the analysis of terbinafine in saline
samples, which could be valuable to aquariums that have to
measure drug concentrations in sea water. Some methods
involved in terbinafine analysis in plasma use MS,[16,18]
but MS equipment is expensive and may not be readily avail-
able to all laboratories. The method described here actually
has the same LLOQ as both[16,18] of the previously reported
MS methods. The Gurule et al.[16] method also required
0.5 mL of plasma to achieve their LLOQ versus the 0.1 mL
sample of this method. The hexane extraction method has a
LLOQ that is more sensitive than many previously described
UV detection methods[1–3,10,11,15] while using a much smaller
sample size than previous methods.[1–3,8,10,14–16] The two
previous methods[8,14] that reported 2 ng=mL LLOQ used a
larger sample volume than the present method to obtain that
level of sensitivity. The present method eliminates the need
for expensive SPE cartridges,[2,3,11,16] online solid phase
equipment,[15] and the use of a robotic liquid handling work-
station.[18] There is no need for sample hydrolysis or multiple
extraction steps, thus eliminating the use of strong acids and
bases, and the additional time needed to perform these
steps.[1,8,10,14,15] The average terbinafine recovery of 90% for
plasma is at least 25% better than most of the reported
plasma methods.[1,4,8–10,14–16,18] The use of butenafine as an
internal standard corrects for the intra- and inter-day assay
variability in the extraction. The LOQ and recovery are more
than adequate for use in pharmacokinetic studies.
Conclusion
In conclusion, this analytical procedure was authenticated in
terms of recovery, linearity, LLOQ, precision, and accuracy.
The results of this study indicate that this HPLC procedure
is a reproducible method that provides consistent quantifi-
cation of terbinafine in plasma and saline. It is a simple
method that eliminates the need for SPE cartridges and
hydrolysis reactions that allows numerous samples to be
processed by a single technician.
This method has been used successfully to determine
terbinafine concentrations in both plasma and saline samples
at this institution. It has been used in the quantitation of
terbinafine in other species and could be applicable to other
groups. This method utilizes a small sample size of 100 mL,
making it potentially useful for small dogs, cats, other small
animals or to those investigators dealing with small sample
volumes, particularly when conducting pharmacokinetic stu-
dies that require multiple sampling from the same animal.
This method would also be valuable to aquariums that need
to determine terbinafine levels in salt water.
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